Zhi Fachao

[Expert Profile] Zhi Fachao, Chief Physician, Professor, Doctoral Supervisor, is an authoritative expert in inflammatory bowel disease and digestive critical care in China, working in the Department of Gastroenterology, Nanfang Hospital, Southern Medical University. He has long been dedicated to clinical diagnosis, treatment, and scientific research of severe inflammatory bowel disease and difficult digestive critical illness, and is an important expert in the field of IBD in China.

[Education & Career] Professor Zhi Fachao graduated from the First Military Medical University (now Southern Medical University), completed systematic clinical training at Nanfang Hospital, and further studied at famous international IBD centers. He has long served as Director of the Department of Gastroenterology at Nanfang Hospital, holding academic positions including Deputy Leader of the Inflammatory Bowel Disease Group of the Gastroenterology Branch of the Chinese Medical Association. He has presided over grants from the National Natural Science Foundation of China and major provincial and ministerial projects, and has accumulated profound clinical and research experience in the field of inflammatory bowel disease.

[Areas of Expertise] Professor Zhi specializes in standardized diagnosis and treatment of inflammatory bowel diseases such as Crohn's disease and ulcerative colitis, with particular expertise in treatment of severe inflammatory bowel disease and difficult digestive critical illness. He has extensive experience in IBD colonoscopy assessment, individualized treatment with biologics and novel drugs, and comprehensive management of IBD-related complications (fistulas, strictures, malnutrition). He excels at developing comprehensive treatment strategies for severe IBD patients with "recurrent conditions and no response to conventional treatment," helping numerous patients control their conditions and avoid surgery.

[Academic Achievements & Industry Contributions] Professor Zhi has led a series of clinical studies on severe inflammatory bowel disease, systematically evaluating the efficacy and safety of different treatment strategies in severe IBD patients, with findings published in authoritative domestic and international journals. He has participated in the development of Chinese inflammatory bowel disease diagnosis and treatment guidelines and expert consensus statements, actively promoted IBD multidisciplinary collaborative diagnosis and treatment and standardized application of biologics, and organized regional IBD specialty collaboration and grassroots training, making important contributions to improving the treatment level of inflammatory bowel disease, particularly severe cases, in China.

[Clinical Practice & Outstanding Contributions] For decades on the front lines of gastroenterology, Professor Zhi has treated tens of thousands of patients with inflammatory bowel disease and various difficult digestive critical illnesses, successfully managing numerous severe IBD patients. He is serious and responsible with patients, working tirelessly, and is deeply trusted by patients. He has repeatedly organized IBD patient education activities and free clinics, actively promoting social care and support for IBD patients, and is an outstanding expert in the field of inflammatory bowel disease in southern China.

[Honors & Reputation] Professor Zhi Fachao serves as Director of the Department of Gastroenterology at Nanfang Hospital, Southern Medical University and Deputy Leader of the Inflammatory Bowel Disease Group of the Gastroenterology Branch of the Chinese Medical Association, among other academic positions. He has presided over grants from the National Natural Science Foundation of China and major provincial and ministerial projects, and is an important expert in the field of inflammatory bowel disease in southern China. He has profound expertise in the diagnosis and treatment of severe inflammatory bowel disease and difficult digestive critical illness. He has led the establishment of an IBD multidisciplinary collaborative diagnosis and treatment system, promoted standardized application of biologics and endoscopic assessment, and participated in the development of multiple inflammatory bowel disease diagnosis and treatment guidelines. For decades on the clinical front lines, he has successfully treated numerous severe IBD patients, and is deeply trusted by patients and respected by peers alike.